Research science professional with 20+ years of experience spearheading research initiatives, synergizing advanced computational and experimental methodologies to unravel complex biological mechanisms and discover new medicines.Co-founder of Nynex Therapeutics, pioneering the development of reversible-covalent compounds that leverage cellular protein degradation machinery to create new oncology medicines. Recently Director of Biophysics at Totus Medicines, a biotech with a proprietary platform to develop new medicines using covalent compounds. Previously at Atomwise, a biotech developing and applying new AI technologies to improve the process of drug discovery. Led a computational and experimental structural biology laboratory as a faculty member at the University of Michigan Medical School. Published scientific advances on three structure/function projects with cell signaling proteins: • Explaining the chemical and molecular basis behind the regulation of protein kinase enzymes • Developing new chemical compounds to target proteins in the ubiquitin-proteasome pathway for cancer therapy • Understanding how transcription factor proteins bind specific DNA sequences and regulate gene expressionSpecialized in molecular dynamics and computational chemistry techniques. In the wet lab, purify and express proteins to carry out molecular structure determination with x-ray crystallography as well as biochemical, proteomic, and biophysical experiments, and drug activity assays.